Functionalized nonporous silica nanoparticles as carriers for Pt(iv) anticancer prodrugs
- 23 September 2016
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 45 (43) , 17233-17240
Abstract
Nonporous silica nanoparticles (SNPs) with an external shell containing primary amino groups were proposed as potential delivery systems for Pt(IV) antitumor prodrugs. Spherical SNPs containing two different external arms, i.e. 3-aminopropyl and N-(6-aminohexyl)aminomethylene, of around 125 nm hydrodynamic diameter were loaded with two different cisplatin-based Pt(IV) complexes, namely (OC-6-44)-diamminedichloridoethoxidosuccinatoplatinum(IV) and (OC-6-44)-diamminedichloridoacetylamidosuccinatoplatinum(IV), through the formation of amide bonds between the pendant amino groups on SNPs and the free carboxylic group of the complexes. In the presence of the N-(6-aminohexyl)aminomethylene arm, the Pt(IV)–SNP conjugates showed a negligible (unwanted) Pt release by hydrolysis, whereas in the presence of ascorbic acid the reduction of Pt(IV) → Pt(II) caused the substantial release of the active metabolite cisplatin. Conjugate Pt(IV)–SNP exhibited better antiproliferative activity on the Pt-sensitive A2780 human ovarian cancer cell line than the parent cisplatin and their free Pt(IV) precursors, due to their more efficient cellular uptake, likely by endocytosis.Keywords
Funding Information
- Compagnia di San Paolo (project BIPLANES)
This publication has 51 references indexed in Scilit:
- Nanostructured materials functionalized with metal complexes: In search of alternatives for administering anticancer metallodrugsCoordination Chemistry Reviews, 2016
- Nanocarriers for delivery of platinum anticancer drugsAdvanced Drug Delivery Reviews, 2013
- Nano-functionalization of metal complexes for molecular imaging and anticancer therapyCoordination Chemistry Reviews, 2013
- Targeted delivery of platinum-based anticancer complexesCurrent Opinion in Chemical Biology, 2013
- Strategies in the design of nanoparticles for therapeutic applicationsNature Reviews Drug Discovery, 2010
- The status of platinum anticancer drugs in the clinic and in clinical trialsDalton Transactions, 2010
- Nanoparticles for drug delivery: The need for precision in reporting particle size parametersEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Antitumour metal compounds: more than theme and variationsDalton Transactions, 2007
- The resurgence of platinum-based cancer chemotherapyNature Reviews Cancer, 2007
- Targeting platinum anti-tumour drugs: Overview of strategies employed to reduce systemic toxicityCoordination Chemistry Reviews, 2005